W A Grasser - Concepedia

Concepedia

Author

W A Grasser

Pfizer (United States)

Also Known As

W A Grasser, W Grasser, W. A. Grasser, W. Grasser, W.A. Grasser, WILLIAM A. GRASSER, William A Grasser, William A. Grasser, William Grasser

38

Publications

3.8K

Citations

25

H-Index

93

Concepts

All Affiliations

Pfizer (United States)Johns Hopkins University United States Military Academy Johns Hopkins Medicine University of Zagreb

WA

About

W A Grasser is an author at Pfizer (United States) specializing in medicine, osteoporosis, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	26	3.3K
2	Health Sciences	6	6	1.9K
3	Natural Sciences	5	5	171
4	Engineering	3	3	171
5	Public Health	2	2	98

W A Grasser

×

32

Publications

3.8K

Citations

25

H-Index

	Year	Citations
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. Masahiko Sato, W A Grasser, Naoto Endo, Journal of Clinical Investigation Tissue EngineeringRat BoneBone SurfaceOsteoporosisOrthopaedic Surgery	1991	1K
Deletion of the P2X<sub>7</sub>Nucleotide Receptor Reveals Its Regulatory Roles in Bone Formation and Resorption Hua Zhu Ke, Hong Qi, A. Frederik Weidema, Molecular Endocrinology SclerostinMolecular BiologyBone FormationRegulatory RolesOrthopaedic Surgery	2003	289
Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family Vishwas Paralkar, Amy L. Vail, W A Grasser, Journal of Biological Chemistry	1998	288
Effects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy Masahiko Sato, W A Grasser Journal of Bone and Mineral Research Bone ImagingElectron MicroscopyMicroscopyReflected Light MicroscopyMedicine	1990	268
Echistatin is a potent inhibitor of bone resorption in culture. Masahiko Sato, M K Sardana, W A Grasser, The Journal of Cell Biology SclerostinBone ResorptionAntibody LocalizationOsteoporosisBone Morphogenic Protein	1990	200
An EP2 receptor-selective prostaglandin E<sub>2</sub>agonist induces bone healing Vishwas Paralkar, Fran Borovečki, H.Z. Ke, Proceedings of the National Academy of Sciences Prostaglandin E2Molecular PhysiologySclerostinBone Morphogenic ProteinMedicine	2003	185
Effects of CP-336,156, a New, Nonsteroidal Estrogen Agonist/Antagonist, on Bone, Serum Cholesterol, Uterus, and Body Composition in Rat Models Hua Zhu Ke, Vishwas Paralkar, W A Grasser, Endocrinology GynecologyRat ModelsFemale Reproductive FunctionNonsteroidal Estrogen Agonist/antagonistOsteoporosis	1998	157
Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis Leonard Buckbinder, David T. Crawford, Hong Qi, Proceedings of the National Academy of Sciences SclerostinCoupled ActionsHigh Bone MassBone FormationOsteoporosis	2007	154
Parathyroid hormone-related protein in the rat urinary bladder: a smooth muscle relaxant produced locally in response to mechanical stretch. Michiko Yamamoto, Sandra C. Harm, W A Grasser, Proceedings of the National Academy of Sciences Muscle FunctionParathyroid DiseaseParathyroid GlandCellular PhysiologySkeletal Muscle	1992	151
Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Mark A. Thiede, Steven L. Smock, Donna N. Petersen, Endocrinology ImmunologyPlatelet PathobiologyTotal RnaOsteoporosisBone Marrow Megakaryocytes	1994	137

Page 1